Articles

Photobiomodulation and gynaecological cancer therapy-related complications: What is known?

BJMO - volume 18, issue 1, february 2024

M. Claes MSc, E. Vandaele MSc, J. Robijns PhD, J. Mebis MD

SUMMARY

Cancer treatment options are steadily improving, but the resulting side effects remain a significant burden. Some of these adverse events can occur in the genitourinary system and often lack a comprehensive management approach. Photobiomodulation therapy (PBM) uses visible or (near)-infrared light to stimulate tissue regeneration. This narrative review discusses the most common cancer therapy-related adverse events in the genitourinary sphere, the causative factors, their current treatment options, and the possible use of PBM in their management strategies. The findings suggest that PBM has the potential to be effective in the treatment of gynaecological cancer therapy-related complications, but further research is required.

(BELG J MED ONCOL 2024;18(1):4–9)

Read more